Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Hansa Biopharma
  4. Hansa Biopharma — Juni 2024

Hansa Biopharma — Juni 2024

Planlagt Fastgjort Låst Flyttet Hansa Biopharma
63 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #34

    Nytransplanterad efter 17 år i dialys

    "Två njurtransplantationer som barn hade gett Mikaela Persson så mycket antikroppar att det var svårt att hitta en matchande njure. Med en ny behandling blev en tredje transplantation till sist verklighet."

    Link Preview Image
    Nytransplanterad efter 17 år i dialys - Njurfonden

    Två njurtransplantationer som barn hade gett Mikaela Persson så mycket antikroppar att det var svårt att hitta en matchande njure.

    favicon

    Njurfonden (www.njurfonden.se)

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #35

      "Det känns helt fantastiskt att börja året med en ny njure"

      Godt mere flere positive historier fra patienter som har været igennem processen ...

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #36

        Tak exitnu for dine indlæg 🙂

        1 Reply Last reply
        0
        • R Offline
          R Offline
          Rasbom
          wrote on sidst redigeret af
          #37

          Ja også et tak herfra exitnu (-:

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #38

            Hansa Biopharma sidst i denne korte video: https://proinvestor.com/boards/121002

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #39

              Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above

              https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-expanded-us-fda-approval-elevidys?_ga=2.70363152.1041565330.1718893358-1568418063.1716906982

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #40

                Blev godkendt!

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #41

                  – FDA grants traditional approval to ELEVIDYS for ambulatory Duchenne patients

                  – FDA grants accelerated approval to ELEVIDYS for non-ambulatory Duchenne patients

                  – Sarepta will host an investor conference call on June 21, 2024, at 8:30 a.m. ET

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #42

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      LP90
                      wrote on sidst redigeret af
                      #43

                      Godmorgen 🙂 super nyhed exitnu

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #44

                        God morgen 🙂

                        1 Reply Last reply
                        0
                        • SEACOPS Offline
                          SEACOPS Offline
                          SEACOP
                          wrote on sidst redigeret af
                          #45

                          @exitnu. Tak for alle dine indlæg gennem tiden. I dag med
                          et af de absolut bedste 🙂

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #46

                            Mange tak til ALLE.

                            1 Reply Last reply
                            0
                            • exitnuE Offline
                              exitnuE Offline
                              exitnu
                              wrote on sidst redigeret af
                              #47

                              Kursudviklingen for Sarepta Therapeutics efter børstid kommer ikke til at blive afspejlet direkte, da DMD-aftalen kun udgør en mindre del/værdi af Hansa Biopharmas portefølje, som eksempelvis nævnt i en tidligere analyse fra Penser Access (nu overtaget af Carnegie).

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #48

                                Sarepta Therapeutics surges 36% after-hours following expanded FDA approval

                                Just a moment...

                                favicon

                                (www.investing.com)

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #49

                                  ... vi må se på mandag, hvordan det går 🙂

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #50

                                    Det bliver spændende. 🙂

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #51

                                      Sarepta's DMD gene therapy secures much-sought-after label expansion https://firstwordpharma.com/story/5868924

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #52

                                        Kursudviklingen for Sarepta Therapeutics er ganske pæn i US i dag fredag 🙂

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #53

                                          Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

                                          Link Preview Image
                                          Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval

                                          Sarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its Duchenne muscular dystrophy gene therapy.

                                          favicon

                                          Investor's Business Daily (www.investors.com)

                                          "The approval expands the market for Elevidys by more than tenfold, Leerink Partners analyst Joseph Schwartz said. Under the original approval, about 7% of patients were eligible for the gene therapy. Now, about 80% are eligible, he said in a report."

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper